Literature DB >> 25763364

Endocrine dysfunction in sepsis: a beneficial or deleterious host response?

Valeriu Gheorghiţă1, Alina Elena Barbu2, Monica Livia Gheorghiu3, Florin Alexandru Căruntu4.   

Abstract

Sepsis is a systemic, deleterious inflammatory host response triggered by an infective agent leading to severe sepsis, septic shock and multi-organ failure. The host response to infection involves a complex, organized and coherent interaction between immune, autonomic, neuroendocrine and behavioral systems. Recent data have confirmed that disturbances of the autonomic nervous and neuroendocrine systems could contribute to sepsis-induced organ dysfunction. Through this review, we aimed to summarize the current knowledge about the endocrine dysfunction as response to sepsis, specifically addressed to vasopressin, copeptin, cortisol, insulin and leptin. We searched the following readily accessible, clinically relevant databases: PubMed, UpToDate, BioMed Central. The immune system could be regarded as a "diffuse sensory organ" that signals the presence of pathogens to the brain through different pathways, such as the vagus nerve, endothelial activation/dysfunction, cytokines and neurotoxic mediators and the circumventricular organs, especially the neurohypophysis. The hormonal profile changes substantially as a consequence of inflammatory mediators and microorganism products leading to inappropriately low levels of vasopressin, sick euthyroid syndrome, reduced adrenal responsiveness to ACTH, insulin resistance, hyperglycemia as well as hyperleptinemia. In conclusion, clinical diagnosis of this "pan-endocrine illness" is frequently challenging due to the many limiting factors. The most important benefits of endocrine markers in the management of sepsis may be reflected by their potential to be used as biomarkers in different scoring systems to estimate the severity of the disease and the risk of death.

Entities:  

Keywords:  Sepsis; endocrine dysfunction; hormones; host response; inflammation

Year:  2015        PMID: 25763364      PMCID: PMC4350863          DOI: 10.11599/germs.2015.1067

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  39 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 2.  Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods.

Authors:  Baha M Arafah
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

3.  Elevated plasma vasopressin concentrations during endotoxin and E. coli shock.

Authors:  M F Wilson; D J Brackett; P Tompkins; B Benjamin; L T Archer; L B Hinshaw
Journal:  Adv Shock Res       Date:  1981

Review 4.  The diabetes paradox: diabetes is not independently associated with mortality in critically ill patients.

Authors:  James S Krinsley; Molly Fisher
Journal:  Hosp Pract (1995)       Date:  2012-04

5.  Septic shock and sepsis: a comparison of total and free plasma cortisol levels.

Authors:  J T Ho; H Al-Musalhi; M J Chapman; T Quach; P D Thomas; C J Bagley; J G Lewis; D J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

6.  The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function.

Authors:  Athena F Zuppa; Vinay Nadkarni; Lauren Davis; Peter C Adamson; Mark A Helfaer; Michael R Elliott; John Abrams; Dennis Durbin
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

7.  Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock.

Authors:  Nils G Morgenthaler; Beat Müller; Joachim Struck; Andreas Bergmann; Heinz Redl; Mirjam Christ-Crain
Journal:  Shock       Date:  2007-08       Impact factor: 3.454

8.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 9.  The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis.

Authors:  P C Minneci; K J Deans; P Q Eichacker; C Natanson
Journal:  Clin Microbiol Infect       Date:  2009-04       Impact factor: 8.067

Review 10.  Science review: The brain in sepsis--culprit and victim.

Authors:  Tarek Sharshar; Nicholas S Hopkinson; David Orlikowski; Djillali Annane
Journal:  Crit Care       Date:  2004-09-08       Impact factor: 9.097

View more
  12 in total

1.  Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

Authors:  Aviral Roy; Richard Phillip Dellinger
Journal:  Ann Transl Med       Date:  2016-12

2.  Refining the Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  Scott L Weiss; Joseph A Carcillo; Francis Leclerc; Stephane Leteurtre; Luregn J Schlapbach; Pierre Tissieres; James L Wynn; Jacques Lacroix
Journal:  Pediatrics       Date:  2022-01-01       Impact factor: 9.703

Review 3.  The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3.

Authors:  Renyu Ding; Yulan Meng; Xiaochun Ma
Journal:  Biomed Res Int       Date:  2018-06-07       Impact factor: 3.411

4.  The Value of Decreased Thyroid Hormone for Predicting Mortality in Adult Septic Patients: A Systematic Review and Meta-Analysis.

Authors:  Jae Guk Kim; Hyungoo Shin; Wonhee Kim; Tae Ho Lim; Bohyoung Jang; Youngsuk Cho; Kyu-Sun Choi; Chiwon Ahn; Juncheol Lee; Min Kyun Na
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

5.  Dynamic Changes in Microbiome Composition Following Mare's Milk Intake for Prevention of Collateral Antibiotic Effect.

Authors:  Almagul Kushugulova; Ulrike Löber; Saniya Akpanova; Kairat Rysbekov; Samat Kozhakhmetov; Zhanagul Khassenbekova; Morgan Essex; Ayaulym Nurgozhina; Madiyar Nurgaziyev; Dmitriy Babenko; Lajos Markó; Sofia K Forslund
Journal:  Front Cell Infect Microbiol       Date:  2021-04-21       Impact factor: 5.293

6.  CENTRAL HYPOTHYROIDISM IN SEVERE SEPSIS.

Authors:  S N Benea; M Lazar; A Hristea; R M Hrisca; C M Niculae; R V Moroti
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

Review 7.  Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Authors:  Weronika Wasyluk; Martyna Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

Review 8.  The interplay between intestinal bacteria and host metabolism in health and disease: lessons from Drosophila melanogaster.

Authors:  Adam C N Wong; Audrey S Vanhove; Paula I Watnick
Journal:  Dis Model Mech       Date:  2016-03       Impact factor: 5.758

9.  Assessment of Diagnostic and Prognostic Role of Copeptin in the Clinical Setting of Sepsis.

Authors:  Stefania Battista; Umberto Audisio; Claudia Galluzzo; Matteo Maggiorotto; Monica Masoero; Daniela Forno; Elisa Pizzolato; Marco Ulla; Manuela Lucchiari; Annarita Vitale; Corrado Moiraghi; Enrico Lupia; Fabio Settanni; Giulio Mengozzi
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

10.  Selected Biomarkers Correlate with the Origin and Severity of Sepsis.

Authors:  Michal Holub; Olga Džupová; Michaela Růžková; Alžběta Stráníková; Eva Bartáková; Jan Máca; Jiří Beneš; Heiko Herwald; Ondřej Beran
Journal:  Mediators Inflamm       Date:  2018-03-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.